Comparison of Ante- versus Retrograde Access for the Endovascular Treatment of Long and Calcified Femoropopliteal Occlusive Lesions.
- Conditions
- I79.2Peripheral angiopathy in diseases classified elsewhere
- Registration Number
- DRKS00015277
- Lead Sponsor
- GRN Klinik Weinheim
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 202
Inclusion Criteria
Patients who were referred to our department for endovascular treatment of femoropopliteal lesions due to claudication or critical limb ischemia
Exclusion Criteria
Patients with acute or subacute limb ischemia, Patients with non-occlusive lesions, Patients with occlusive lesions in less than 2 femoropopliteal vessel segments or occlusive lesions with only mild or no calcification, Patients with restenosis or occlusions in regions with previous implanted stents, Patients with occlusion length<10 cm.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is vessel patency at 6 month follow-up (clinical evaluation).<br>The primary endpoint will be assessed at 6 months after the intervention.<br>The primary endpoint will be assessed through an interview by telephone. <br>The patient will be asked if: <br>- pain is present when walking <br>- after how many meters does the pain start<br>- is there an improvement<br>- if wounds were present before the intervention, are the wounds closed<br>- another intervention was necessary in the last 6 months (either endovascular or surgical)<br>- a leg amputation occured
- Secondary Outcome Measures
Name Time Method procedural time, radiation exposure and contrast agent administration, number and total length of implanted stents, peri- and postprocedural complications